Evidence map›Paper›PMID 29914962›Full record

ArticleAntimicrobial agents and chemotherapy2018

Frédéric Robin, Michel Auzou, Richard Bonnet, Romain Lebreuilly, Christophe Isnard, Vincent Cattoir, François Guérin

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.9field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Novel Antibiotics for Gram-Negative Nosocomial Pneumonia.Antibiotics (Basel, Switzerland) · 2024
    Review
  3. Article
  4. Article
  5. New Perspectives on Antimicrobial Agents: Ceftolozane-Tazobactam.Antimicrobial agents and chemotherapy · 2021
    Review
  6. Review
  7. Review
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Frédéric RobinCHU Clermont-Ferrand, Laboratoire de Bactériologie et CNR de la Résistance aux Antibiotiques, Clermont-Ferrand, France.
Michel AuzouCHU de Caen, Service de Microbiologie, Caen, France.
Richard BonnetCHU Clermont-Ferrand, Laboratoire de Bactériologie et CNR de la Résistance aux Antibiotiques, Clermont-Ferrand, France.
Romain LebreuillyLaboratoire InterPsy (groupe GRC), Université de Lorraine, Nancy, France.
Christophe IsnardCHU de Caen, Service de Microbiologie, Caen, France.
Vincent CattoirCHU de Rennes, Service de Bactériologie-Hygiène Hospitalière et CNR de la Résistance aux Antibiotiques, Rennes, France vincent.cattoir@chu-rennes.fr.ORCID 0000-0003-4026-9912
François GuérinUMR INSERM 1071 USC INRA2018, Université Clermont Auvergne, Clermont-Ferrand, France.
Inserm · FRCentre Hospitalier Universitaire de Caen Normandie · FRInterpsy · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The study evaluated the

Indexed as

Anti-Bacterial AgentsBacterial Proteinsbeta-Lactamase Inhibitorsbeta-LactamasesCephalosporinsEnterobacter cloacaeEnterobacteriaceae InfectionsHumansMicrobial Sensitivity TestsPhenotypeTazobactamAmpC beta-lactamasesAnti-Bacterial AgentsBacterial Proteinsbeta-Lactamase Inhibitorsbeta-Lactamasesceftolozaneceftolozane, tazobactam drug combinationCephalosporinsTazobactamAmpCceftolozaneECCE. cloacae complexESBLtazobactamTOL-TAZ

Identifiers

PMID29914962
PMCPMC6125531
OpenAlexW2809180019

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.